Sws Partners Guardant Health, Inc. Transaction History
Sws Partners
- $315 Million
- Q4 2024
A detailed history of Sws Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sws Partners holds 120,888 shares of GH stock, worth $5.01 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
120,888
Previous 83,762
44.32%
Holding current value
$5.01 Million
Previous $1.92 Million
92.34%
% of portfolio
1.17%
Previous 0.62%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$500 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$466 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$266 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$226 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$217 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.24B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...